Daniel Brattström
University College Dublin · 78 works · 1,102 citations · h-index 18
Top works
- FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer
- Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
- Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients
- HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival
- P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy.
- HER-2, EGFR, COX-2 Expression status correlated to microvessel density and survival in resected non-small cell lung cancer
- High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study
- Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer
- Esophageal cancer: current and emerging therapy modalities
- Irradiation of brain metastases from lung cancer: A retrospective study
- Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review.
- Impact of age at diagnosis on prognosis and treatment in laryngeal cancer
- Evaluation of radiation-induced DNA damage and DNA repair in human lung cancer cell lines with different radiosensitivity using alkaline and neutral single cell gel electrophoresis
- The Presence of Anti-p53 Antibodies in Sera Prior to Thoracic Surgery in Non Small Cell Lung Cancer Patients: Its Implications on Tumor Volume, Nodal Involvement, and Survival
- p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer.
- Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma.
- First Results from FACT – An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer.
- Complete sequence of p53 gene in 20 patients with lung cancer: comparison with chemosensitivity and immunohistochemistry
- Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma
- Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma